Abstract:Lupus, Ahead of Print. BackgroundSystemic lupus erythematosus (SLE) is a complex autoimmune connective tissue disease (CTD) that is an important cause of devastating pulmonary arterial hypertension (PAH), and persistent progression of PAH can lead to right heart failure, predicting a poor prognosis for SLE patients. Right ventricular-pulmonary arterial (RV-PA) coupling with echocardiography has been demonstrated to be a noninvasive alternative method for evaluating PAH patients' predictive outcomes. Whether the ratio of right ventricular stroke volume (RVSV) to right ventricular end-systolic volume (RVESV) measured by three-dimensional echocardiography (3DE) is a new index of RV-PA coupling has not been discussed as a new predictor for the clinical outcome of systemic lupus erythematosus-associated pulmonary arterial hypertension (SLE-PAH).MethodsFrom June 2019 to February 2023, 46 consecutive patients with SLE-PAH were enrolled prospectively, and their clinical data and echocardiographs were studied and analyzed. The control group consisted of 30 healthy subjects matched for age, sex, and body surface area (BSA). The main endpoints of this study were a composite of all-cause mortality and adverse clinical events. Baseline clinical characteristics and echocardiographic assessments were analyzed.ResultsDuring a median of 24 months (IQR 18–31), 16 of 46 SLE-PAH patients (34.7%) experienced endpoint-related events. At baseline, patients who experienced mortality or adverse events had a worse WHO functional class (WHO FC) and lower anti-double-stranded DNA (dsDNA) antibody levels. The right ventricular (RV) systolic dysfunction in SLE-PAH subjects was significantly worse than that in the healthy control group, especially in SLE-PAH patients in the endpoint event group. Compared to controls, patients with SLE-PAH had a lower RVSV/RVESV ratio. In the group comparison, patients who had experienced an endpoint event had a sequentially worse ratio (1.86 (1.65–2.3) versus 1.30 (1.09–1.46) versus 0.64 (0.59-0.67), p < .001). There were statistically significant associations between the RVSV/RVESV ratio to routine RV systolic function and clinical parameters. The RVSV/RVESV ratio was negatively correlated with the WHO FC (r = −0.621, p < .001) and positively correlated with the anti-dsDNA level. The ROC curve showed that the optimal cutoff for RVSV/RVESV 0.712 was associated with more favorable long-term outcomes.ConclusionsThe 3DE-derived SV/ESV ratio as a noninvasive alternative surrogate of RV-PA coupling was an eximious indicator for identifying endpoint events in SLE-PAH patients and can provide a diagnostic basis for clinical intervention.

[Assessment Right Atrial Function in Patients with Systemic Lupus Erythematosus by Speckle Tracking and Three-Dimensional Echocardiography].

Assessment of Left Atrial Strain in Patients Pre-and Post-Mitral Valvuloplasty by Using Two-Dimensional Speckle Tracking Echocardiography

Evaluation of Left Atrial Function by Real-time 3-D Echocardiography in Patients with Systemic Lupus Erythematosus

Evaluation of left atrial function by speckle tracking echocardiography in patients with systemic lupus erythematosus

Applying real-time three-dimensional echocardiography with Tei index to assessment of the right heart function in patients with systemic lupus erythematous

Quantitative Assessment of Right Ventricular Function in Patients with Systemic Lupus Erythematosus Using the Novel Non-invasive Pressure–Strain Loop

Study on the Feasibility of Evaluating Right Ventricular Function Injury in SLE Patients by Echocardiography

Biventricular Tissue Tracking Demonstrating Associations Between Left Ventricular Myocardial Extracellular Volume, Pulmonary Artery Pressure, and Reduced Right Ventricular Ejection Fraction in Patients with Systemic Lupus Erythematosus Using Cardiovascular MRI

Prognostic impact of right atrial strain in systemic lupus erythematosus with pulmonary arterial hypertension

Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking

Evaluation of right ventricular systolic function by speckle tracking imaging in patients with rheumatoid arthritis

Assessment Right Atrial Funtion in Patients with Hepatocirrhosis by Real-time 3D Echocardiography and 2D Speckle Tracking Imaging

Effect of Systemic Lupus Erythematosus on Right Heart Function Evaluated by Parameters Recommended by the American Society of Echocardiography

Peak Strain Dispersion Within the Left Ventricle Detected by Two-Dimensional Speckle Tracking in Patients with Uncomplicated Systemic Lupus Erythematosus.

Evaluation of Ventricular Systolic Function in Patients with Rheumatoid Arthritis Using Two-Dimensional Speckle Tracking Echocardiography

Comparative Study of Radionuclide Ventriculography and Echocardiography in Assessment of Cardiac Involvement in Patients with Systemic Lupus Erythematosus

Evaluation of Left Atrial Function in Patients with Hypertension by Real-Time Three-dimensional Echocardiography and Two-dimensional Speckle Tracking Imaging

Assessment of left atrial function by speckle tracking imaging and real-time three-dimensional echocardiography in patients with essential hypertension

Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients

Right Atrial Function in Patients with Pulmonary Hypertension: A Study with Two-Dimensional Speckle-Tracking Echocardiography.

Two-dimensional Speckle Tracking Imaging Evaluates Global and Regional Systolic Function on Right Ventricle in Adult Patients with Atrial Septal Defect